Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment Seoul, Jan 31: Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administrat...
